logo
Overview
Discover
Watchlists
Portfolios
Heatmap
Sectors
Trendscore
Performers
Alerts
Options
Earnings
Screeners
Scanners
Backtests
Strategies
Comparisons
Charts
Sign in
IRIX
IRIDEX Corporation
1.15
1 x 0.83
2 x 1.52
bid
ask
-
0.02
1.71%
09:30 AM
timesize
Ytd0.88%
1y29.21%
1.15
day range
1.15
0.87
52 week range
1.65
Open1.15Prev Close1.17Low1.15High1.15Mkt Cap20.02M
Vol1.76KAvg Vol255.74KEPS-0.19P/EN/AForward P/E-5.85
Beta0.81Short Ratio7.38Inst. Own20.06%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-1850-d Avg1.09200-d Avg1.161yr Est2.00

IRIX News

Iridex to Present at the Planet MicroCap Las Vegas 2026 Conference
globenewswire.com
Iridex to Present at the Planet MicroCap Las Vegas 2026 Conference

MOUNTAIN VIEW, Calif., June 09, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldw

IRIX Stock Up 4% As Q1 Loss Narrows Y/Y on Glaucoma Product Growth
zacks.com
IRIX Stock Up 4% As Q1 Loss Narrows Y/Y on Glaucoma Product Growth

IRIDEX posts a narrower year-over-year net loss per share in Q1'26 as strong glaucoma product sales

IRIDEX Corporation (IRIX) Q1 2026 Earnings Call Transcript
seekingalpha.com
IRIDEX Corporation (IRIX) Q1 2026 Earnings Call Transcript

IRIDEX Corporation (IRIX) Q1 2026 Earnings Call Transcript

Iridex Q1 2026 Earnings Call: Complete Transcript
benzinga.com
Iridex Q1 2026 Earnings Call: Complete Transcript
benzinga.com
Iridex Affirms FY2026 Sales Guidance of $51.000M-$53.000M vs $53.227M Est

Iridex (NASDAQ:IRIX) affirms FY2026 sales outlook from $51.000 million-$53.000 million to $51.000 mi
benzinga.com
Iridex Q1 EPS $(0.03) Beats $(0.07) Estimate, Sales $11.799M Miss $11.910M Estimate

Iridex (NASDAQ:IRIX) reported quarterly losses of $(0.03) per share which beat the analyst consensus

Iridex Reports First Quarter 2026 Financial Results
globenewswire.com
Iridex Reports First Quarter 2026 Financial Results

MOUNTAIN VIEW, Calif., May 19, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwi

Earnings Scheduled For May 19, 2026
benzinga.com
Earnings Scheduled For May 19, 2026

Iridex to Report First Quarter 2026 Financial Results on May 19, 2026
globenewswire.com
Iridex to Report First Quarter 2026 Financial Results on May 19, 2026

MOUNTAIN VIEW, Calif., May 05, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwi

12 Health Care Stocks Moving In Tuesday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session

Iridex Announces New Partnership with EyeProGPO to Expand Member Access to Retina Laser Technology
globenewswire.com
Iridex Announces New Partnership with EyeProGPO to Expand Member Access to Retina Laser Technology

MOUNTAIN VIEW, Calif., April 07, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a world

Iridex's Q4 Loss Narrows Year Over Year on Retina Sales Growth
zacks.com
Iridex's Q4 Loss Narrows Year Over Year on Retina Sales Growth

IRIX incurs narrower year-over-year loss per share in Q4 as growth in retina systems and glaucoma pr

12 Health Care Stocks Moving In Friday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session

IRIDEX Corporation (IRIX) Q4 2025 Earnings Call Transcript
seekingalpha.com
IRIDEX Corporation (IRIX) Q4 2025 Earnings Call Transcript

IRIDEX Corporation (IRIX) Q4 2025 Earnings Call Transcript
benzinga.com
Iridex Q4 EPS $(0.01) Beats $(0.02) Estimate, Sales $14.724M Miss $14.740M Estimate.

Iridex (NASDAQ:IRIX) reported quarterly losses of $(0.01) per share which beat the analyst consensus

Iridex Reports Fourth Quarter and Full Year 2025 Financial Results
globenewswire.com
Iridex Reports Fourth Quarter and Full Year 2025 Financial Results

Strong Q4 and Full Year 2025 Revenue Performance Underpinned by Continued Operational Efficiencies S

Earnings Scheduled For March 26, 2026
benzinga.com
Earnings Scheduled For March 26, 2026

IRIDEX (IRIX) Projected to Post Earnings on Thursday
defenseworld.net
IRIDEX (IRIX) Projected to Post Earnings on Thursday

IRIDEX (NASDAQ: IRIX - Get Free Report) is expected to issue its Q4 2025 results before the market o

Iridex to Report Fourth Quarter and Full Year 2025 Financial Results on March 26, 2026
globenewswire.com
Iridex to Report Fourth Quarter and Full Year 2025 Financial Results on March 26, 2026

MOUNTAIN VIEW, Calif., March 12, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a world

Iridex Announces Plans to Relocate Headquarters
globenewswire.com
Iridex Announces Plans to Relocate Headquarters

MOUNTAIN VIEW, Calif., Feb. 02, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldw

12 Health Care Stocks Moving In Friday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session

12 Health Care Stocks Moving In Monday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Monday's Intraday Session
benzinga.com
Iridex Reports Preliminary Q4 2025 Revenue Of $14.6M–$14.8M, Up 15%–17% YoY, And Full-Year Revenue O

Fourth Quarter 2025 ResultsTotal revenue is expected to be between $14.6 million and $14.8 million c

Iridex Announces Preliminary Operational and Financial Results for Fourth Quarter and Full Year 2025
globenewswire.com
Iridex Announces Preliminary Operational and Financial Results for Fourth Quarter and Full Year 2025

MOUNTAIN VIEW, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldw

Zacks Initiates Coverage of Iridex With Neutral Recommendation
zacks.com
Zacks Initiates Coverage of Iridex With Neutral Recommendation

Discover why Zacks initiated coverage of IRIX with a "Neutral" rating, being the first on Wall Stree
benzinga.com
New Study Shows Iridex Laser Treatment Safely Lowers Eye Pressure for Glaucoma Patients

Iridex Corporation (NASDAQ:IRIX), a worldwide leader providing innovative and versatile laser-based

Iridex Announces the Publication of an Independent Study Demonstrating Safe and Effective Retreatment with Transscleral Laser Treatment Using MicroPulse® Technology in Glaucoma Management
globenewswire.com
Iridex Announces the Publication of an Independent Study Demonstrating Safe and Effective Retreatmen

MOUNTAIN VIEW, Calif., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldw

Iridex Announces New Thermal Dynamics Study That Strengthens Clinical Foundation and Market Potential of MicroPulse® Technology and Continuous-Wave Laser for Glaucoma Treatment
globenewswire.com
Iridex Announces New Thermal Dynamics Study That Strengthens Clinical Foundation and Market Potentia

MOUNTAIN VIEW, Calif., Dec. 08, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldw

Iridex to Present at the Sidoti Year-End Virtual Investor Conference
globenewswire.com
Iridex to Present at the Sidoti Year-End Virtual Investor Conference

MOUNTAIN VIEW, Calif., Dec. 05, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldw

12 Health Care Stocks Moving In Wednesday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session

12 Health Care Stocks Moving In Wednesday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Why LightPath Technologies Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket
benzinga.com
Why LightPath Technologies Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket

IRIDEX Corporation (IRIX) Q3 2025 Earnings Call Prepared Remarks Transcript
seekingalpha.com
IRIDEX Corporation (IRIX) Q3 2025 Earnings Call Prepared Remarks Transcript

IRIDEX Corporation ( IRIX ) Q3 2025 Earnings Call November 11, 2025 5:00 PM EST Company Participants
benzinga.com
Iridex Q3 EPS $(0.09) Up From $(0.12) YoY, Sales $12.484M Up From $11.581M YoY

Iridex (NASDAQ:IRIX) reported quarterly losses of $(0.09) per share. This is a 25 percent increase o

Iridex Reports Third Quarter 2025 Financial Results
globenewswire.com
Iridex Reports Third Quarter 2025 Financial Results

MOUNTAIN VIEW, Calif., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldw

Earnings Scheduled For November 11, 2025
benzinga.com
Earnings Scheduled For November 11, 2025

Iridex to Report Third Quarter 2025 Financial Results on November 11, 2025
globenewswire.com
Iridex to Report Third Quarter 2025 Financial Results on November 11, 2025

MOUNTAIN VIEW, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldw
benzinga.com
CORRECTION: Iridex Q2 EPS $(0.06) Misses $0.06 Estimate, Sales $13.57M Up From $12.63M YoY

Iridex (NASDAQ:IRIX) reported quarterly losses of $(0.06) per share which missed the analyst consens
benzinga.com
Earnings Scheduled For August 12, 2025
benzinga.com
12 Health Care Stocks Moving In Thursday's After-Market Session

12 Health Care Stocks Moving In Tuesday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
benzinga.com
Iridex Q1 GAAP EPS $(0.10) Up From $(0.21) YoY, Sales $11.90M Up From $11.76M YoY

Iridex (NASDAQ:IRIX) reported quarterly losses of $(0.10) per share. This is a 52.38 percent increas
benzinga.com
Earnings Scheduled For May 13, 2025
benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session
benzinga.com
Iridex Q4 EPS $(0.05) Up From $(0.18) YoY, Sales $12.70M Up From $12.46M YoY

Iridex (NASDAQ:IRIX) reported quarterly losses of $(0.05) per share. This is a 72.22 percent increas
benzinga.com
Earnings Scheduled For March 27, 2025
benzinga.com
Earnings Preview For Iridex
benzinga.com
Iridex Announces $10M Investment From Novel Inspiration; $6M Series B Preferred Stock Sale & $4M Con

Iridex Corporation (NASDAQ:IRIX), a worldwide leader providing innovative and versatile laser-based